MJH Life Sciences Acquires the Pharmacy Benefit Management Institute


PBMI informs, advises, and influences the industry on drug cost management.

MJH Life Sciences™ has announced it has acquired the Pharmacy Benefit Management Institute (PBMI) from Pharmaceutical Strategies Group (PSG). This latest addition to the MJH portfolio broadens its leadership position in managed care at a crucial time for medicine in our country.

“Credible information is critical to health care professionals during this global pandemic, and education about how it will impact drug benefit management is vital,” said Mike Hennessy Jr., president and CEO of MJH Life Sciences™, in a prepared statement. “For 25 years, PBMI’s annual meeting has been a driver of change within the marketplace, and as part of our Managed Markets Network, we look forward to growing the conference to make an even bigger impact in the field of managed care.”

As the leading provider of research and education for the pharmacy benefit market, PBMI informs, advises, and influences the industry on drug cost management. PBMI provides a forum for purchasers to exchange ideas, and drive marketplace changes that improve pharmacy benefits and control costs. The company offers a wide range of services, including research, continuing education and web resources to help all critical stakeholders work better together to optimize the overall value of drug benefit programs. PBMI is based in Plano, Texas.

“We are appreciative of the many years we have worked in partnership with PBMI,” said Dave Borden, CEO of PSG, in a prepared statement. “We are proud to have provided a home for PBMI to fulfill its mission to provide quality information and education around best practices and cutting-edge clinical and drug cost management strategies and solutions in community with the industry associates, PBM partners, and PSG friends and colleagues who have supported PBMI conferences and events.

“After careful consideration, we have decided to give PBMI a new home where it can continue its mission and prosper for many years to come,” Borden added. “MJH Life Sciences™ is a global business with significant resources and experience in the area of conference management and education, and we are confident the organization will enable PBMI to further its mission and reach new heights. We look forward to continuing our relationship with PBMI and hope to see our friends, partners, and colleagues at PBMI events for many years to come.”

The sale includes PBMI’s trademarks, conference, website, education and membership assets. All current and future research and analytics projects will continue through PSG under the leadership of Sharon Frazee, PhD, MPH, SVP Research & Data Innovation.


MJH Life Sciences™ Acquires the Pharmacy Benefit Management Institute (PBMI) [news release]. Cranbury, NJ; April 2, 2020: MJH Life Sciences. https://www.businesswire.com/news/home/20200402005508/en/MJH-Life-Sciences%E2%84%A2-Acquires-Pharmacy-Benefit-Management Accessed April 2, 2020.

Related Videos
Aimee Keegan, PharmD, BCOP, a clinical pharmacist
Aimee Keegan, PharmD, BCOP, a clinical pharmacist
Video 2 - "Achieving Post-Discharge Success: Goals in Hepatic Encephalopathy Care"
Video 1 - "Identifying and Screening for Hepatic Encephalopathy Risk Factors"
© 2024 MJH Life Sciences

All rights reserved.